Although patients with primary carcinoma of the liver are better operative risks, the incidence of recurrent growth is about 60%. Patients with non-malignant cirrhotic disease are more apt to develop perioperative complications, but having survived the first few weeks their chances of long-term rehabilitation are better than are those of patients with malignant conditions. Many of the earlier patients in this series would now be considered too ill for the procedure, but still about half of the patients accepted for grafting die before a donor liver becomes available, and some patients who are suitable when first seen are gravely ill by the time a liver graft can be performed.
A slow but steady improvement in survival after liver grafting has resulted from multiple and interacting factors. These include patient selection; technical changes, particularly regarding biliary drainage; increased availability of donors with transport of livers between different centres; and new immunosuppressive management.
Although patients with primary carcinoma of the liver are better operative risks, the incidence of recurrent growth is about 60%. Patients with non-malignant cirrhotic disease are more apt to develop perioperative complications, but having survived the first few weeks their chances of long-term rehabilitation are better than are those of patients with malignant conditions. Many of the earlier patients in this series would now be considered too ill for the procedure, but still about half of the patients accepted for grafting die before a donor liver becomes available, and some patients who are suitable when first seen are gravely ill by the time a liver graft can be performed.
We Indications and restrictions for grafting AGE We have not been able to obtain livers from children and, therefore, cannot offer this operation to patients with biliary atresia. Previously, the side effects of steroids were a further contraindication to grafting children but immunosuppression with cyclosporin A does not usually require additional long-term steroids.' The surgical risks are greater for patients over 55. Thus our policy is to consider only patients past puberty and under 55.
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Pathology of the non-malignant conditions Most of our cases have been of non-alcoholic aetiology, as alcoholic patients tend to be unreliable in hospital attendance and taking medication. Primary biliary cirrhosis, chronic active hepatitis, and the Budd-Chiari syndrome are the most common indications for liver grafting. Australia antigenaemia is a relative contraindication because of the risk to the staff and also the danger to the graft from reinfection. For prevention of the latter, hyperimmune globulin is given to the patient during the anhepatic phase, and one of our patients is well at five and a half years and the blood has remained antigen free.2 Recrudescence of the patient's original disease in the graft is a possibility in any cirrhotic disease with a primary autoimmune basis. Evidence to suggest that this may occur has been obtained recently in three patients transplanted for primary biliary cirrhosis. The first signs were observed during the third year after grafting (J Neuberger et al, unpublished observations). The use of possibly hepatotoxic immunosuppressive drugs can be a complicating factor, and the distinction from one of the clinical varieties of chronic rejection may be difficult. Patients who had suffered from the BuddChiari syndrome are kept anticoagulated with warfarin, since, in a case when this was not done, the hepatic veins rethrombosed.
Of the malignant conditions, primary hepatocellular carcinoma and cholangiocarcinoma arising within the liver constitute the largest group. Scirrhous carcinoma arising at the junction of bile ducts in porta hepatitis (Klatskin tumour) and hepatic secondary deposits are not suitable; our experience has shown that there is usually rapid recurrence of these tumours.
Assessment
For patients with non-malignant disease, liver grafting should be considered when it is realised that the disease is preventing the patient from living a satisfactory life. Recurrent variceal bleeding, incapacitating encephalopathy, or weakness making the patient bedridden or housebound are specific instances. We admit the patients to hospital for assessment and to enable them to meet the nurses and doctors who will look after them. If the patient is medically suitable and he and his relatives have fully understood the risks of the procedure, he is accepted for transplantation.
A systolic blood pressure below 100 mm Hg, infection, severe impairment of clotting tests, and a blocked portal vein are contraindications. For patients with liver cancer a biopsy is required to confirm the diagnosis. Intravenous pyelography and barium studies of the gastrointestinal tract are performed to exclude an occult primary cancer in the kidney or colon, because these two sites are the most likely to give rise to hepatic metastases, which may be difficult to distinguish from primary hepatocellular carcinoma or cholangiocarcinoma. Abdominal computerised and skeletal scanning and tomography of both lungs are also carried out to exclude extrahepatic metastases, but micrometastases (particularly in lymph nodes within the porta hepatis) will not be detected, and this risk must be accepted.
The operation
The operation has been described in detail elsewhere.' A team of surgeons, anaesthetists, nurses, and technicians familiar with the procedure require the active support of a well-staffed blood bank and biochemical laboratory. The criteria for a suitable donor are a compatible ABO red cell group, no systemic infection or malignancy, no history of liver disease or alcoholism, normal liver function test results, and the absence of Australia antigenaemia. The operation takes two to three hours of careful dissection with the circulation intact in a donor who has died as a result of cerebral destruction. Overhydration of the donor and excessive infusion of cooling fluid of extracellular ionic content through the portal vein combined with hypotension may give rise to an oedematous, ischaemically damaged liver that will not perfuse when grafted. The kidneys are also removed for grafting. The liver is cooled by perfusion through the portal vein and hepatic artery. Bile from the gall bladder and major bile ducts is washed with cold perfusate. Since this modification was introduced two years ago there have been no cases of sloughing of the biliary epithelium that had often caused obstruction of bile flow.4 While the liver is cold and unperfused on an operating "work bench" the gall bladder is mobilised and the common bile duct is anastomosed to an incision in Hartman's pouch, this anastomosis being splinted with a T tube. This is done either before or after the liver has been stored in 
Patients with satisfactory progress are allowed up at one week and are discharged from hospital with the T tube spigotted three to six weeks postoperatively.
Results
Of the 108 recipients of liver allografts over the past 13 years, 20 are alive and 15 of these have survived more than six months; six are alive at between four and five and a half years. Of the 100 patients transplanted more than six months ago, 36 survived beyond six months (table I) 
In the early phase of this programme most of the deaths resulted from complications of biliary drainage, perioperative haemorrhage, and acute heart failure. Of those grafted for malignant disease who survived six months, 60% succumbed to recurrence of tumour. Of the 22 patients grafted in the past 21 months, 13 are alive one week to 18 months later, giving a current one-year survival rate of over 50%. Two patients died from bleeding before the operation could be completed. The causes of death in nine of the last 22 cases are listed in table II. Septicaemia is now the main lethal complication, and the four patients who died were still receiving azathioprine and steroids. Three had been given high steroid dosage because of rejection. We now plan to change patients to cyclosporin A in the first week after grafting before rejection is likely to occur, since bacterial infection has been less common in our renal allograft recipients treated with cyclosporin A than in those treated with azathioprine and prednisolone. Rehabilitation in survivors who have left hospital has been excellent, but continuing bone pain and osteoporosis in cirrhotic patients with pre-existing bone disease has been aggravated by the steroids. This complication should become less common with the increasing use of cyclosporin A.
Discussion
The results of orthotopic liver allografting have slowly improved. Our experience is similar to that in Denver, where about 200 patients have received liver grafts. Starzl's longest survivor is well after more than 10 years, and two of his female patients have given birth to normal children after liver transplantation.7 The perioperative mortality of patients with primary malignancy of the liver is below that of cirrhotic patients because the former usually have good liver function in the non-affected hepatic parenchyma. The cancer recurrence rate of 60% in patients surviving six months, however, has prompted us to change from operating predominantly on malignant cases to mainly cirrhotic patients. More Although a formidable procedure, transplantation of the liver may give excellent rehabilitation to young patients for whom there is no alternative treatment. The costs and use of resources may well be less than those of prolonged care in hospital of patients dying of liver diseases. In economic terms liver grafting is sound if the patient is restored to useful activity; in human terms no justification is necessary.
(Accepted 20 May 1981) What are the chances of an abnormality developing in the infant of a woman who was taking the oral contraceptive norethisterone acetate (Norlestrin) during the first three months of pregnancy ?
Norlestrin, in Britain and Australia, consists of 2-5 mg norethisterone acetate and 0 05 mg ethinyloestradiol. It is a standard "combined" oral contraceptive, with no greater or smaller chance of causing fetal abnormality than any other such preparation. The question of whether or not oral contraceptives cause fetal abnormality is difficult to answer, and the risk is not substantiated.' Although administration of some oestrogens or progestogens to pregnant rats may cause abnormalities of sex differentiation, combined preparations in animals have not shown teratogenicity.' Women becoming pregnant after stopping the pill do not appear to have an increased chance of fetal abnormality. Among women taking hormones in early pregnancy (either inadvertently or as a treatment for threatened abortion) many possible abnormalities have been reported, including cardiac,3 limb reduction, and genital anomalies.2 4 More than one acronym has been invented to describe these,4 but a definite relationship with oral contraceptives has not been proved. There are no reports of delayed effects as infants grow up after intrauterine exposure to sex hormones, except for the well-known effects of diethylstilboestrol. One wonders whether conclusive information will ever become available, but in the meantime current practice is to discontinue the use of hormonal pregnancy tests, to be cautious in using hormones to treat or "prevent" threatened abortion, and to reassure pregnant women who have inadvertently taken the pill that the risk of fetal abnormality is either extremely low or non-existent. Recent reports show that carcinoma of the thyroid gland can be initiated after comparatively low doses of irradiation. How much irradiation of the thyroid occurs during procedures for soft tissue radiography of the neck or the usual anteroposterior and lateral radiographs for investigating lesions of the cervical spine pathology ?
The radiation dose to the thyroid from radiography of the cervical spine or soft tissues of the neck may be calculated by applying Rosenstein'st system for estimating organ doses to the skin doses from diagnostic radiology described by Rogers.2 Thus a typical examination of the cervical spine entailing three radiographs probably results in a dose to the thyroid of around 100 mrads. The risk of radiation carcinogenesis is assumed to be linear with dose and to be without threshold. The induction rate for radiogenic thyroid carcinomas appears to be somewhat higher in females than in males and is probably rather higher in infants and children than in adults. 3 Although the induction rate of thyroid malignancies within 25 years of the time of irradiation is high (50-150 cases per million per rad) compared with other radiationinduced cancers, these tumours have a low mortality, the mortality risk factor being around 10 per million per rad.3 Thus an examination necessitating a thyroid dose of 100 mrads will carry a risk of around one in a million of developing a subsequent fatal malignancy due to the radiation. Although an excess of thyroid cancer has been reported after therapeutic irradiation of the skin of the scalp, and the resultant radiation doses to the thyroid of the order of 5-10 rads, it is most improbable that the risks associated with doses of around 100 mrads would be demonstrable by epidemiological techniques.
